Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,506 | -7,476 | -5,227 | -2,785 | -15,016 |
| Depreciation Amortization | 657 | 504 | 332 | 162 | 651 |
| Accounts receivable | 5 | -127 | -65 | -23 | 50 |
| Accounts payable and accrued liabilities | -451 | -516 | -524 | -524 | 504 |
| Other Working Capital | 794 | -857 | -808 | -793 | 2,536 |
| Other Operating Activity | 3,454 | 2,942 | 2,410 | 1,767 | 3,813 |
| Operating Cash Flow | $-7,047 | $-5,530 | $-3,882 | $-2,196 | $-7,462 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -154 | -88 | -193 | N/A | N/A |
| PPE Investments | 228 | 239 | 277 | -127 | -207 |
| Purchase Sale Intangibles | -309 | -144 | -60 | -31 | -535 |
| Other Investing Activity | -309 | -144 | -60 | -31 | -535 |
| Investing Cash Flow | $-235 | $7 | $24 | $-158 | $-742 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3 | -2 | -2 | -1 | -3 |
| Common Stock Issued | 103 | 103 | 103 | N/A | 4,145 |
| Financing Cash Flow | $100 | $101 | $101 | $-1 | $4,142 |
| Exchange Rate Effect | -82 | -93 | -80 | -52 | -26 |
| Beginning Cash Position | 10,460 | 10,460 | 10,460 | 10,460 | 14,548 |
| End Cash Position | 3,196 | 4,945 | 6,623 | 8,053 | 10,460 |
| Net Cash Flow | $-7,264 | $-5,515 | $-3,837 | $-2,407 | $-4,088 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,047 | -5,530 | -3,882 | -2,196 | -7,462 |
| Capital Expenditure | -310 | -305 | 277 | -127 | -236 |
| Free Cash Flow | -7,357 | -5,835 | -3,605 | -2,323 | -7,698 |